MEIP
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
28
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
emptyResult
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
Recently from Cashu
MEI Pharma (MEIP) Leads Corporate Crypto Adoption with Litecoin Treasury Strategy
MEI Pharma Pioneers Cryptocurrency Adoption in Corporate Treasury Management In a groundbreaking move, San Diego-based MEI Pharma (MEIP) has made headlines by acquiring 929,548 Litecoin (LTC/USD) toke…
MEI Pharma Leads Crypto Adoption with Litecoin in Corporate Treasury Management
MEI Pharma Pioneers Cryptocurrency Adoption in Corporate Treasury Management MEI Pharma, a San Diego-based biotechnology firm, makes headlines with its recent acquisition of 929,548 Litecoin (LTC/USD)…
MEI Pharma Launches $100M Litecoin Treasury Program to Strengthen Financial Position and Innovation
MEI Pharma Ventures into Cryptocurrency with $100 Million Litecoin Treasury Program MEI Pharma has embarked on a transformative journey by initiating a $100 million treasury program centered around Li…
MEI Pharma Launches $100 Million Litecoin Treasury Program to Diversify Financial Strategy
MEI Pharma Expands Financial Horizons with $100 Million Litecoin Treasury Program MEI Pharma, Inc. (MEIP) takes a bold step into the cryptocurrency space by initiating a $100 million treasury program…